+132% (Utilities) – Fueled by massive cost-cutting and asset sale plans.
+95% (Consumer Discretionary) – Benefited from a recovery in the Macau gambling market. stocks to buy right now 2017
+81% (Technology) – Continued its dominance by expanding from gaming into AI and data centers. +132% (Utilities) – Fueled by massive cost-cutting and
Small-to-mid cap biotechs saw astronomical gains; Madrigal Pharmaceuticals (MDGL) rose 516% , while Sangamo Therapeutics (SGMO) gained 438% . The Losers: Madrigal Pharmaceuticals (MDGL) rose 516%
For the first time in years, all 45 countries tracked by the OECD were in a growth phase simultaneously. Refining Your Investment View
A high-profile laggard, dropping 44.8% during the year. Under Armour (UAA): Plummeted over 50% . Why the Market Surged
+103% (Healthcare) – Gained on breakthroughs in cystic fibrosis drug trials.